Literature DB >> 17191137

Tetrahydrobiopterin availability in Parkinson's and Alzheimer's disease; potential pathogenic mechanisms.

Richard H Foxton1, John M Land, Simon J R Heales.   

Abstract

Within the central nervous system, tetrahydrobiopterin (BH4) is an essential cofactor for dopamine and serotonin synthesis. In addition, BH4 is now established to be an essential cofactor for all isoforms of nitric oxide synthase (NOS). Inborn errors of metabolism affecting BH4 availability are well documented and the clinical presentation can be attributed to a paucity of dopamine, serotonin, and nitric oxide (NO) generation. In this article, we have focussed upon the sensitivity of BH4 to oxidative catabolism and the observation that when BH4 is limiting some cellular sources of NOS may generate superoxide whilst other BH4 saturated NOS enzymes may be generating NO. Such a scenario could favor peroxynitrite generation. If peroxynitrite is not scavenged, e.g., by antioxidants such as reduced glutathione, irreversible damage to critical cellular enzymes could ensue. Such targets include components of the mitochondrial electron transport chain, alpha ketoglutarate dehydrogenase and possibly pyruvate dehydrogenase. Such a cascade of events is hypothesized, in this article, to occur in neurodegenerative conditions such as Parkinson's and Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17191137     DOI: 10.1007/s11064-006-9201-0

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  25 in total

1.  Reduced nitric oxide metabolites in CSF of patients with tetrahydrobiopterin deficiency.

Authors:  Giovanna Zorzi; Beat Thöny; Nenad Blau
Journal:  J Neurochem       Date:  2002-01       Impact factor: 5.372

2.  Widespread peroxynitrite-mediated damage in Alzheimer's disease.

Authors:  M A Smith; P L Richey Harris; L M Sayre; J S Beckman; G Perry
Journal:  J Neurosci       Date:  1997-04-15       Impact factor: 6.167

3.  Structural basis of biopterin-induced inhibition of GTP cyclohydrolase I by GFRP, its feedback regulatory protein.

Authors:  Nobuo Maita; Kazuyuki Hatakeyama; Kengo Okada; Toshio Hakoshima
Journal:  J Biol Chem       Date:  2004-09-23       Impact factor: 5.157

4.  Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture.

Authors:  J P Bolaños; S J Heales; J M Land; J B Clark
Journal:  J Neurochem       Date:  1995-05       Impact factor: 5.372

5.  Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia.

Authors:  María Delgado-Esteban; Angeles Almeida; Jose M Medina
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

6.  Inhibition of monocyte luminol-dependent chemiluminescence by tetrahydrobiopterin, and the free radical oxidation of tetrahydrobiopterin, dihydrobiopterin and dihydroneopterin.

Authors:  S J Heales; J A Blair; C Meinschad; I Ziegler
Journal:  Cell Biochem Funct       Date:  1988-07       Impact factor: 3.685

7.  Nitric oxide synthase and neuronal vulnerability in Parkinson's disease.

Authors:  S Hunot; F Boissière; B Faucheux; B Brugg; A Mouatt-Prigent; Y Agid; E C Hirsch
Journal:  Neuroscience       Date:  1996-05       Impact factor: 3.590

8.  Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brains of normal controls and patients with senile dementia of Alzheimer type.

Authors:  M Sawada; Y Hirata; H Arai; R Iizuka; T Nagatsu
Journal:  J Neurochem       Date:  1987-03       Impact factor: 5.372

9.  Glutathione depletion in nigrostriatal slice cultures: GABA loss, dopamine resistance and protection by the tetrahydrobiopterin precursor sepiapterin.

Authors:  Jan Bert Gramsbergen; Mats Sandberg; Annette Møller Dall; Brian Kornblit; Jens Zimmer
Journal:  Brain Res       Date:  2002-05-10       Impact factor: 3.252

10.  Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease.

Authors:  Y Vodovotz; M S Lucia; K C Flanders; L Chesler; Q W Xie; T W Smith; J Weidner; R Mumford; R Webber; C Nathan; A B Roberts; C F Lippa; M B Sporn
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  20 in total

1.  The N-terminal peptide of mammalian GTP cyclohydrolase I is an autoinhibitory control element and contributes to binding the allosteric regulatory protein GFRP.

Authors:  Christina E Higgins; Steven S Gross
Journal:  J Biol Chem       Date:  2010-12-16       Impact factor: 5.157

2.  Autophagy induction by tetrahydrobiopterin deficiency.

Authors:  Sang Su Kwak; Jinkyu Suk; Ji Hye Choi; Seungkyung Yang; Jin Woo Kim; Seonghyang Sohn; Jae Hoon Chung; Yong Hee Hong; Dong Hwan Lee; Jeong Keun Ahn; Hyesun Min; Ya-Min Fu; Gary G Meadows; Cheol O Joe
Journal:  Autophagy       Date:  2011-11-01       Impact factor: 16.016

Review 3.  Tetrahydrobiopterin and Its Multiple Roles in Neuropsychological Disorders.

Authors:  S Swathi Krishna; Samson K Wilson
Journal:  Neurochem Res       Date:  2022-02-10       Impact factor: 3.996

4.  Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease.

Authors:  C Sampath; R Kalpana; T Ansah; C Charlton; A Hale; K M Channon; S Srinivasan; P R Gangula
Journal:  Dig Dis Sci       Date:  2019-06-11       Impact factor: 3.199

Review 5.  Oxidative Stress, GTPCH1, and Endothelial Nitric Oxide Synthase Uncoupling in Hypertension.

Authors:  Yin Wu; Ye Ding; Tharmarajan Ramprasath; Ming-Hui Zou
Journal:  Antioxid Redox Signal       Date:  2020-05-27       Impact factor: 8.401

6.  Tetrahydrobiopterin availability, nitric oxide metabolism and glutathione status in the hph-1 mouse; implications for the pathogenesis and treatment of tetrahydrobiopterin deficiency states.

Authors:  A A J Lam; K Hyland; S J R Heales
Journal:  J Inherit Metab Dis       Date:  2007-01-22       Impact factor: 4.750

7.  Non-covalent interaction between polyubiquitin and GTP cyclohydrolase 1 dictates its degradation.

Authors:  Yu Zhao; Huaiping Zhu; Ming-Hui Zou
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

8.  Differential Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on Motor Behavior and Dopamine Levels at Brain Regions in Three Different Mouse Strains.

Authors:  Keun-Sung Lee; Jin-Koo Lee; Hyung-Gun Kim; Hak Rim Kim
Journal:  Korean J Physiol Pharmacol       Date:  2013-02-14       Impact factor: 2.016

9.  Amelioration of behavioral abnormalities in BH(4)-deficient mice by dietary supplementation of tyrosine.

Authors:  Sang Su Kwak; Mikyoung Jeong; Ji Hye Choi; Daesoo Kim; Hyesun Min; Yoosik Yoon; Onyou Hwang; Gary G Meadows; Cheol O Joe
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

10.  The Protective Effect of Minocycline in a Paraquat-Induced Parkinson's Disease Model in Drosophila is Modified in Altered Genetic Backgrounds.

Authors:  Arati A Inamdar; Anathbandhu Chaudhuri; Janis O'Donnell
Journal:  Parkinsons Dis       Date:  2012-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.